Ilios Therapeutics
PrivateLast Round
Seed
Sep 5, 2023
Company Overview
Ilios Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in September 2023.
Ilios Therapeutics is a biotechnology company that develops multi-functional, brain-penetrant small molecules to treat neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ilios Therapeutics Comparables
Compare Ilios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muna Therapeutics | 79% | |
| Arkuda Therapeutics | 77% | |
| Eikonizo Therapeutics | 77% |
For institutional investors. Book with your work email.
Ilios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2023 | ||||
| Accelerator | Jul 11, 2022 | ||||
| Pre Seed | Apr 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ilios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Launch Lab | Pre Seed |
| Harvard Innovation Labs | Pre Seed |
| Club degli Investitori | Seed |
| Catalisi | Seed |
| MassChallenge Israel | Accelerator, Pre Seed |
| InnoSpark Ventures | Seed |
| Exor Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2023
Seed round raised with participation from Exor Ventures and 3LB Seed Capital.
- Jul 11, 2022
Received funding from MassChallenge Israel.
For institutional investors. Book with your work email.
Ilios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ilios Therapeutics's valuation, stock price, and market status.
Is Ilios Therapeutics a public or private company?
Ilios Therapeutics is a private company.
What is the current stock price of Ilios Therapeutics?
Ilios Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ilios Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ilios Therapeutics worth (valuation)?
Valuation information for Ilios Therapeutics is not publicly available.
Can I buy Ilios Therapeutics stock?
Ilios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ilios Therapeutics's last funding round?
Ilios Therapeutics's most recent funding round was Seed on September 5, 2023.
Who are the main investors in Ilios Therapeutics?
Key investors in Ilios Therapeutics include Harvard Innovation Launch Lab, Harvard Innovation Labs, Club degli Investitori, Catalisi, MassChallenge Israel.
Will Ilios Therapeutics IPO soon?
No public IPO plans have been announced for Ilios Therapeutics.
How can I track Ilios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ilios Therapeutics's shares on secondary markets.